Also trades as: DR.TO (TSX) · $vol 0M
MFCSF OTC
Medical Facilities Corporation
1W: -1.1%
1M: -5.7%
3M: -15.9%
YTD: -8.1%
1Y: +2.1%
3Y: +56.5%
5Y: +57.5%
$10.41
-0.06 (-0.57%)
Weekly Expected Move ±1.9%
$10
$10
$10
$11
$11
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$259M
-22.0% ▼
5Y CAGR: -6.6%
Gross Profit
$98M
-55.3% ▼
5Y CAGR: -16.6%
Operating Income
$47M
-23.0% ▼
5Y CAGR: -6.9%
Net Income
$21M
-71.3% ▼
5Y CAGR: -10.8%
EPS (Diluted)
$1.08
-64.7% ▼
5Y CAGR: -2.1%
EBITDA
$59M
-28.1% ▼
5Y CAGR: -9.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $399M | $425M | $446M | $332M | $259M |
| YoY Growth | +9.6% | +6.5% | +5.0% | -25.6% | -22.0% |
| Cost of Revenue | $130M | $144M | $283M | $112M | $160M |
| Gross Profit | $269M | $281M | $163M | $220M | $98M |
| Gross Margin | 67.4% | 66.1% | 36.5% | 66.3% | 38.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $178M | $198M | $75M | $151M | $51M |
| Operating Expenses | $191M | $229M | $96M | $158M | $51M |
| Operating Income | $77M | $47M | $67M | $62M | $47M |
| Operating Margin | 19.4% | 11.1% | 15.1% | 18.6% | 18.4% |
| Interest Expense | $6M | $13M | $17M | $4M | $4M |
| Income Before Tax | $51M | $18M | $52M | $51M | $40M |
| Tax Expense | $4M | $5M | $8M | -$6M | $5M |
| Net Income | $46M | $12M | $19M | $73M | $21M |
| Net Margin | 11.7% | 2.9% | 4.2% | 22.2% | 8.2% |
| EPS (Diluted) | $1.49 | $0.42 | $0.73 | $3.06 | $1.08 |
| EBITDA | $103M | $43M | $78M | $83M | $59M |
| Shares Outstanding | 31M | 29M | 25M | 24M | 19M |